Endogenous cannabinoids as an aversive or
counter-rewarding system in the rat
by
CSanudo-Pena MC, Tsou K, Delay ER,
Hohman AG, Force M, Walker JM.
Schrier Research Laboratory,
Department of Psychology, Brown University,
Providence, RI 02912, USA.
clara@poppy.psych.brown.edu
Neurosci Lett. 1997 Feb 21;223(2):125-
ABSTRACTHuman use of marijuana (Cannabis sativa) is widely assumed to have rewarding properties, a notion supported by its widespread recreational use. However, no study has clearly demonstrated such effects in animal models. The purpose of this study was to test for the presumed rewarding effect of cannabinoids using a conditioned place preference paradigm. The results showed that animals failed to develop place conditioning at a low dose (1.5 mg/kg) and developed a place aversion at a high dose (15 mg/kg) of the active principle in marijuana, delta 9-tetrahydrocannabinol (delta 9-THC), a finding consistent with most previous studies. Moreover, the administration of the cannabinoid antagonist SR141716A induced a conditioned place preference at both a low (0.5 mg/kg) and a high (5 mg/kg) dose. In summary, cannabinoid antagonism produced place preference while cannabinoid agonism induced place aversion. These results suggest that endogenous cannabinoids serve normally to suppress reward or to induce aversion.Dopamine
Endocannabinoids
Stoned as a newt?
The nectar of delight
Stoned chocaholics?
Rodent cannabis abuse
Cannabis-tainted money
Cannabis and schizophrenia
Cannabinoids/Parkinson's disease01 02 03 04 05 06 07 08 09 10 11 12 13 14 15
Refs
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
The Hedonistic Imperative
MDMA: Utopian Pharmacology
When Is It Best To Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family
